Australian Packaging Stock News

Oil prices are back in focus after U.S. strikes on Iranian targets, the end of a ceasefire, and a fresh clampdown on Iranian crude exports pushed Brent and WTI up by more than 5%. For energy investors, that kind of shock can quickly reshape expectations around cash flows, costs, and risk across oil and gas producers. This article looks at how that news links to a curated screener of large, financially solid oil and natural gas stocks, and highlights 3 stocks that appear positively exposed to...

Inflation policy is moving from the background to centre stage, and that matters directly for your portfolio. With governments exploring profit caps, price controls and new taxes on essential services, some stocks now look far more exposed to regulatory risk than others. This article focuses on the news pressure now circling companies in energy, healthcare, education and childcare, and why that matters if you care about protecting capital. Below, you will find 3 stocks from our Inflation...

Virgin Media’s record £28 million Ofcom fine has put customer treatment and regulatory risk firmly back in the spotlight for telecom stocks. When one major operator is punished for obstructive cancellation tactics, investors often reassess which companies might benefit from stricter oversight and shifting customer trust. This article looks at how that news could ripple across larger telecommunications stocks screens, particularly those with stronger health and performance scores. You will see...

When a major network failure at Telstra can stall emergency calls, payments, and freight across Australia in a single day, it underlines how central resilient telecommunications infrastructure has become to everyday life and business continuity. For investors, outages like this can reshape expectations around reliability, backup capacity, and regulatory pressure. This article looks at how that shock filters through to larger companies involved in telecom infrastructure and resilience, and...

New US tariffs on imports from 60 countries are set to ripple through global trade, raising questions about costs, pricing power, and resilience across logistics and supply chain stocks. For investors watching how freight forwarding, shipping, and warehousing companies handle higher friction at the borders, this is a moment to reassess exposure rather than simply react to headlines. This article walks through three stocks from our Logistics and Supply Chain Solutions screener that appear...

Ionic Rare Earths’ grant-backed recycling plans could give this ASX rare earths stock a clearer test of its China-free supply chain thesis.

Energy shocks, war headlines and interest rate uncertainty are back at the center of markets, with Brent crude recently surging over 50% and central banks warning about future supply and inflation risks. When oil, inflation and rates move together, some stocks can benefit from higher pricing power or stronger demand, while others face rising costs or pressure on funding. This article looks at 3 stocks exposed to the current Iran war and rate backdrop, including 2 that may gain from these...

Artificial intelligence in healthcare sits at the crossroads of rising global cost pressures, tighter monetary policy debates, and consumers who still want better treatment and access. While inflation, rates, and commodity shocks keep moving the macro picture, AI-driven diagnostics, remote care, and research tools target long term efficiency gains and more accurate care. The Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, personalise...

Recent attention on Lovisa Holdings (ASX:LOV) centres on its international store expansion, brand development and operational execution, as investors evaluate how these efforts relate to comparable sales and the stock’s recent price move. See our latest analysis for Lovisa Holdings. Lovisa Holdings’ recent 11.01% 1 month share price gain contrasts with a year to date share price decline of 22.57% and a 1 year total shareholder return decline of 23.89%, while 3 and 5 year total shareholder...

Automation pressure at Australian ports is turning into a real test for companies tied to global trade. Dock workers pushing for a 28 hour week with full pay, rising AI adoption and the risk of strikes or disruptions can all feed into higher costs, operational hiccups and changing sentiment around logistics exposed stocks. For investors, this is less about headlines and more about understanding which businesses are most directly exposed to the news and where labor, regulatory and technology...

Australian shares are expected to open lower today, influenced by recent geopolitical tensions in the Middle East and a decline in U.S. semiconductor stocks. In such fluctuating market conditions, investors often look beyond well-known names to discover opportunities among smaller or newer companies. Although the term "penny stock" might seem outdated, these investments can still offer substantial value when backed by solid financials and potential for growth.

Insiders who bought AU$1.47m worth of OpenLearning Limited ( ASX:OLL ) stock in the last year have seen some of their...

Insiders who purchased AU$3.43m worth of DigitalX Limited ( ASX:DCC ) shares over the past year recouped some of their...

Betmakers Technology Group Ltd ( ASX:BET ), might not be a large cap stock, but it saw a double-digit share price rise...

Earlier this month, Commonwealth Bank of Australia outlined a slower domestic economic outlook, with its economists projecting A$ GDP growth of about 1.5% in 2026 as softer housing markets and steady interest rates weigh on household spending. At the same time, CBA’s status as Australia’s largest listed bank and a core bluechip is drawing renewed attention as investors refocus on earnings resilience, margins and execution quality over short-term themes. We’ll now explore how this softer...

Elsight (ASX:ELS) drew fresh attention after a 3.11% share price move as investors focused on its role providing connectivity solutions for autonomous and remotely operated systems, particularly drones operating beyond the operator’s line of sight. See our latest analysis for Elsight. The 13.38% 7 day share price return and 15.83% 90 day share price return build on Elsight’s strong year to date momentum of 135.38%, while the 1 year total shareholder return above 400% underlines how sentiment...

The recent 38% drop in Clara Resources Australia Ltd's ( ASX:C7A ) stock could come as a blow to insiders who purchased...

Earlier this week, Bank of Queensland released a fresh financial update that has put the Australian lender and its peers under closer market scrutiny as investors reassess the outlook for the banking sector. This update lands at a time when commodity price moves, global earnings releases and shifting monetary policy expectations are all influencing how investors view banks’ earnings resilience and risk profiles. We’ll now explore how Bank of Queensland’s latest financial update interacts...

The federal government’s review of whether six foreign investors complied with divestment orders in Northern Minerals (ASX:NTU) has sharpened attention on ownership control at the Browns Range heavy rare earths project in Western Australia. See our latest analysis for Northern Minerals. At a share price of A$0.026, Northern Minerals has seen the 1 day share price return fall 13.33%, while the 7 day share price return is up 4.00%, and the 1 year total shareholder return is down 7.14%. This...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Even if it's not a huge purchase, we think it was good to see that Allan Ritchie, the CEO & Executive Chairman of...

Over the last year, a good number of insiders have significantly increased their holdings in Toubani Resources Limited...

Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, recently drew increased attention as its copper-based theranostic programs in cancer imaging and therapy progressed through multiple clinical trials. The company’s proprietary Targeted Copper Theranostics platform, spanning indications from prostate cancer to paediatric oncology, has become a focal point for investors watching upcoming clinical and regulatory milestones. With this backdrop, we’ll examine how excitement...

As the Australian market navigates a cautious phase, influenced by global chip rallies and geopolitical developments, investors are keenly watching for opportunities that align with these shifting dynamics. In such an environment, growth companies with high insider ownership can offer unique insights and potential resilience, making them attractive considerations for those seeking to understand the interplay between internal confidence and market performance.